Evidence map›Paper›PMID 16571735›Full record

ArticleJournal of neurophysiology2006

Somatostatin presynaptically inhibits both GABA and glutamate release onto rat basal forebrain cholinergic neurons.

Toshihiko Momiyama, Laszlo Zaborszky

Open access · greenAbstract read
In one paragraph

Article in Journal of neurophysiology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 58 citations in OpenAlex.

  1. Neuropeptidergic systems in psychiatric disorders.Frontiers in endocrinology · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Specific Basal Forebrain-Cortical Cholinergic Circuits Coordinate Cognitive Operations.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Review
  16. Review
  17. Review
  18. Neurons in the Primate Medial Basal Forebrain Signal Combined Information about Reward Uncertainty, Value, and Punishment Anticipation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Toshihiko MomiyamaDivision of Cerebral Structure, National Institute for Physiological Sciences, Myodaiji, Okazaki 444-8787, Japan. tmomi@nips.ac.jp
Laszlo Zaborszky
National Institute for Physiological Sciences · JP

Funding

AFFERENT REGULATION OF CHOLINERGIC FOREBRAIN NEURONSR01NS023945 · NINDS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI ZABORSZKY, LASZLO · 1986 to 2019
$6.5M
NINDS NIH HHS NS-23945NINDS NIH HHS R01 NS023945
6 · The paper itself

Abstract

A whole cell patch-clamp study was carried out in slices obtained from young rat brain to elucidate the roles of somatostatin in the modulation of synaptic transmission onto cholinergic neurons in the basal forebrain (BF), a region that contains cholinergic and GABAergic corticopetal neurons and somatostatin (SS)-containing local circuit neurons. Cholinergic neurons within the BF were identified by in vivo prelabeling with Cy3 IgG. Because in many cases SS is contained in GABAergic neurons in the CNS, we investigated whether exogenously applied SS can influence GABAergic transmission onto cholinergic neurons. Bath application of somatostatin (1 muM) reduced the amplitude of the evoked GABAergic inhibitory presynaptic currents (IPSCs) in cholinergic neurons. SS also reduced the frequency of miniature IPSCs (mIPSCs) without affecting their amplitude distribution. SS-induced effect on the mIPSC frequency was significantly larger in the solution containing 7.2 mM Ca(2+) than in the standard (2.4 mM Ca(2+)) external solution. Similar effects were observed in the case of non-NMDA glutamatergic excitatory postsynaptic currents (EPSCs). SS inhibited the amplitude of evoked EPSCs and reduced the frequency of miniature EPSCs dependent on the external Ca(2+) concentration with no effect on their amplitude distribution. Pharmacological analyses using SS-receptor subtype-specific drugs suggest that SS-induced action of the IPSCs is mediated mostly by the sst(2) subtype, whereas sst subtypes mediating SS-induced inhibition of EPSCs are mainly sst(1) or sst(4). These findings suggest that SS presynaptically inhibits both GABA and glutamate release onto BF cholinergic neurons in a Ca(2+)-dependent way, and that SS-induced effect on IPSCs and EPSCs are mediated by different sst subtypes.

Indexed as

AnimalsCalciumData Interpretation, StatisticalElectrophysiologyGABA AgonistsGABA Antagonistsgamma-Aminobutyric AcidGlutamic AcidHormone AntagonistsIn Vitro TechniquesNeuronsParasympathetic Nervous SystemPatch-Clamp TechniquesProsencephalonRatsReceptor, Nerve Growth FactorCalciumGABA AgonistsGABA Antagonistsgamma-Aminobutyric AcidGlutamic AcidHormone AntagonistsReceptor, Nerve Growth FactorReceptors, PresynapticSomatostatin

Identifiers

PMID16571735
PMCPMC1850939
OpenAlexW1979035646

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.